Top 10 Common Health Conditions and How Mankind Pharma’s Products Help

Mankind Pharma is at the forefront of the Indian pharmaceutical industry, offering an extensive array of over 500 products that address both acute and chronic health conditions impacting millions across the nation. This blog explores the top 10 common health conditions globally and demonstrates how Mankind Pharma medicines provide essential solutions, improving health outcomes and accessibility for all segments of society. 

The Top 10 Common Health Conditions

The leading health conditions worldwide, according to recent statistics and global health authorities, include cardiovascular diseases, diabetes, respiratory illnesses, gastrointestinal disorders, infectious diseases, cancer, pain/inflammation, neurological disorders, dermatological conditions, and vitamin/mineral deficiencies. These illnesses are responsible for significant morbidity, disability, and economic costs annually. 

1. Cardiovascular Diseases

Cardiovascular ailments remain the highest cause of mortality globally. In fact, approximately 80% of the 20.5 million CVD-related deaths in 2021 occurred in low- and middle-income countries.  Ischaemic heart disease (IHD) is one of the leading causes of death and disease burden in India affecting all age groups. Mankind Pharma’s cardiovascular portfolio comprises drugs like Amliokind-AT (Amlodipine), Telmikind-H (Telmisartan), Telmikind-AM (Telmisartan) that are leading products in the cardiovascular space. 

2. Diabetes

Globally, about 830 million people worldwide have diabetes and India has almost 90 million people affected by the disease. Mankind’s Diabetes Specialities Division has two Super Speciality Diabetes Teams, Nobelis launched in 2020 and Diacar in 2022 (acquired from Panacea Biotec). Nobelis has a pan-India reach and focuses on both Type 1 and type 2 diabetes with products like Glargine, Dapagliflozin, Vildagliptin, Voglibose, and their combinations. Diacar, on the other hand, focuses on type 2 diabetes with its flagship brand Glizid.

3. Respiratory Diseases

Respiratory illnesses like asthma and chronic obstructive pulmonary disease (COPD) are among the leading causes of disability. Mankind offers drugs like Monticope (Montelukast), Asthakind-DX (Dextromethorphan), and inhalers to manage symptoms and improve quality of life for respiratory patients. 

4. Gastrointestinal Disorders

Digestive problems such as acidity, indigestion, and gastric ulcers are common in India due to dietary habits. Medicines like Pantakind (Pantoprazole), Rabeprazole (Rabekind), and combination antacids from Mankind Pharma help maintain gut health and support better digestion. The company also offers probiotics and digestive enzymes, enhancing nutrient absorption and gut flora balance. 

5. Infectious Diseases

Anti-infective drugs are a broad category of medications designed to combat infections caused by pathogens such as bacteria, viruses, fungi, and parasites. These drugs include antibiotics, antiviral agents, antifungal medications, and antiparasitics. Mankind Pharma is a leader in anti-infectives, with Azithromycin (Zady), Amoxicillin-Clavulanic Acid (Moxikind-CV), and Fluconazole (Nuforce) forming the first line of defense against bacterial and fungal infections. 

6. Cancer

Cancer cases are rising globally. In 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths. Mankind Pharma is currently developing first in class novel therapeutics for the treatment of melanoma and lung cancer. Mankind is also working on Immuno-oncology,  an innovative and promising approach to cancer treatment that harnesses the body’s immune system to recognize, attack, and eliminate cancer cells.

7. Autoimmune Disorders

Autoimmune disorders arise when the immune system mistakenly attacks healthy tissues, affecting quality of life and often managed only by symptom-relieving treatments. Autoimmune disorders include Celiac disease, dermatomyositis, Graves disease, Hashimoto thyroiditis, inflammatory bowel disease (Crohn disease, ulcerative colitis), multiple sclerosis, myasthenia gravis, rheumatoid arthritis, systemic lupus erythematosus (lupus), and Type I diabetes.

Mankind Pharma is aiming for novel therapeutics that could have potential therapeutic effect on umbrella of inflammatory diseases such as rheumatoid arthritis. ulcerative colitis, plaque psoriasis, and alopecia.

8. Neurological Disorders

Over 1 in 3 people affected by neurological conditions, and neurological disorders are the leading cause of disability and the second leading cause of death worldwide. 

There are hundreds of neurological disorders, and they can be classified into several categories:

• Neurodegenerative conditions: Alzheimer’s disease, multiple sclerosis, Parkinson’s disease.
• Neuromuscular conditions: Muscular dystrophy, amyotrophic lateral sclerosis.
• Brain conditions: Epilepsy, migraines and headache disorders, stroke, traumatic brain injury.
• Spine conditions: Spina bifida, spinal cord injury, spinal muscular atrophy.
• Peripheral nerve conditions: Peripheral neuropathy, carpal tunnel syndrome, Bell’s palsy.

Mankind Pharma has developed the capacity to produce antipsychotics, antidepressants, anxiolytics and benzodiazepines to provide robust pharmaceutical support for patients. 

9. Dermatological Issues

Globally, skin conditions are estimated to affect 1.8 billion people at any point in time.  Skin infections, which can be of bacterial, viral, fungal, or parasitic origin, are the commonest cause of disease, especially in tropical and resource-poor settings.  

Mankind Pharma produces a range of antifungal and acne medicines to treat dermatological diseases. Candiforce (Itraconazole) AcneStar (Clindamycin) Terbinaforce  (Terbinafine)

10. Vitamin and Mineral Deficiencies

Micronutrients, including vitamins and minerals, are vital for the production of hormones, enzymes and, other substances that manage growth and development. Diseases caused by deficiencies of iron (anaemia), iodine [(iodine deficiency (IDD) disorders such as goitre and hypothyroidism] and vitamin A [vitamin A deficiency (VAD) disorders such as blindness] are considered major public health problems.

The prevalence of micronutrient deificiencies in India is widespread. For example,  Vitamin B12, vitamin A and vitamin D deficiencies (VDDs) range between 14 and 31 % for pre-school children and adolescents

The vitamins / minerals / nutrients portfolio of Mankind Pharma features multivitamins and nutrients, including vitamin B-12, mecobalamin, and arginine combinations.

Mankind Pharma’s Commitment: Affordability and Accessibility

Mankind Pharma’s reach extends beyond urban markets, focusing on making quality medicines affordable and accessible in India’s rural heartland. Over 50% of the population resides in villages, and Mankind’s vast distribution network ensures their products—covering anti-infectives, painkillers, diabetes management, and more—are within everyone’s reach. 

The company’s dedication to R&D, advanced manufacturing, and a sustainable supply chain makes it a trusted leader with a patient-centric ethos. Their growth in chronic segment prescriptions underscores both demand and the effectiveness of their strategies in combating non-communicable diseases. 

By addressing the world’s most common diseases with a comprehensive, accessible, and affordable portfolio, Mankind Pharma medicines have become indispensable in the fight against prevalent health conditions. Whether for heart disease, diabetes, infections, or deficiencies, Mankind Pharma ensures quality treatment is accessible for all, contributing significantly to healthier lives and a stronger society.